News
Cantor Fitzgerald, a financial services firm, that it entered into a definitive agreement to acquire UBS’s O’Connor ...
Detailed price information for Oric Pharmaceuticals Inc (ORIC-Q) from The Globe and Mail including charting and trades.
Zacks Investment Research on MSN5d
UBS Group's Arm to Divest O'Connor Business to Cantor FitzgeraldLLC, has announced a definitive agreement to sell O’Connor, its hedge fund, private credit, and commodities business, to ...
The global investment platform of financial services firm Cantor Fitzgerald is launching a new product that will allow ...
The Cantor Fitzgerald Gold Protected Bitcoin Fund, which the firm said will be its first BTC-focused investment vehicle, is ...
Cantor Fitzgerald analyst Prakhar Agrawal commented on the results, stating, "Overall, a solid update by ORIC with not much to nitpick on efficacy/safety." Agrawal reiterated an Overweight rating on ...
InvestorsHub on MSN6d
ORIC Pharmaceuticals Shares Rally 20% on Encouraging Cancer Drug Trial and Funding UpdateShares of ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) jumped 20% following the release of early data from its ongoing Phase 1b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback